References
- Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan’s failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol. 2015;212(3):405–06. doi:10.1016/j.ajog.2014.11.037.
- Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, et al. Realistic fear of cervical cancer risk in Japan depending on birth year. Hum Vaccin Immunother. 2017;13(7):1700–04. doi:10.1080/21645515.2017.1292190.
- Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, Miyagi E, Sekine M, Enomoto T, Kudoh K. HPV vaccination in Japan: what is happening in Japan? Expert Rev Vaccines. 2019;18(4):323–25. doi:10.1080/14760584.2019.1584040.
- Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385(9987):2571. doi:10.1016/S0140-6736(15)61152-7.
- Ueda Y, Yagi A, Nakayama T, Hirai K, Ikeda S, Sekine M, Miyagi E, Enomoto T. Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year. Sci Rep. 2018;8(1):5612. doi:10.1038/s41598-018-23947-6.
- Yagi A, Ueda Y, Ikeda S, Sekine M, Nakayama T, Miyagi E, Enomoto T. Evaluation of future cervical cancer risk in Japan, based on birth year. Vaccine. 2019;37(22):2889–91. doi:10.1016/j.vaccine.2019.04.044.
- Masayuki S, Risa K, Manako Y, Sharon JBH, Megumi H, Sosuke A, Yutaka U, Etsuko M, Sayaka I, Asami Y, et al. Japan’s ongoing crisis on HPV vaccination. Vaccines. 2020;8(3):362. doi:10.3390/vaccines8030362.
- Luostarinen T, Apter D, Dillner J, Eriksson T, Harjula K, Natunen K, Paavonen J, Pukkala E, Lehtinen M. Vaccination protects against invasive HPV-associated cancers. Int J Cancer. 2018;142(10):2186–87. doi:10.1002/ijc.31231.
- Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Hpv SP. Vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–48. doi:10.1056/NEJMoa1917338.
- Yagi A, Ueda Y, Nakagawa S, Ikeda S, Tanaka Y, Sekine M, Miyagi E, Enomoto T, Kimura T. Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine. Sci Rep. 2020;10(1):15945. doi:10.1038/s41598-020-73106-z.
- Ueda Y, Yagi A, Ikeda S, Enomoto T, Kimura T. Beyond resumption of the Japanese Government’s recommendation of the HPV vaccine. Lancet Oncol. 2018;19(12):1563–64. doi:10.1016/S1470-2045(18)30573-4.
- Taniguchi M, Ueda Y, Yagi A, Ikeda S, Endo M, Tomimatsu T, Nakayama T, Sekine M, Enomoto T, Kimura T. Cervical cancer screening rate differs by HPV vaccination status: an interim analysis. Vaccine. 2019;37(32):4424–26. doi:10.1016/j.vaccine.2019.06.064.
- Miyoshi A, Ueda Y, Yagi A, Taniguchi M, Sekine M, Enomoto T, Kimura T. Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods. Hum Vaccin Immunother. 2020;3:1–5.
- Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Morimoto A, Terai Y, Ohmichi MCT, Sumi T, Murata H, Okada H, et al. Development of an efficient strategy to improve HPV immunization coverage in Japan. BMC Public Health. 2016;16(1):1013. doi:10.1186/s12889-016-3676-7.
- Miyoshi A, Takiuchi T, Kimura T. HPV vaccination in Japan: can educational intervention promote a father’s intention to encourage his daughter’s vaccination? Int J Clin Oncol. 2020;25(4):746–54. doi:10.1007/s10147-019-01575-y.
- Taniguchi M, Ueda Y, Yagi A, Miyoshi A, Tanaka Y, Minekawa R, Endo M, Tomimatsu T, Hirai K, Nakayama T, et al. Disparity of cervical cancer risk in young Japanese women: bipolarized status of HPV vaccination and cancer screening. Vaccines (Basel). 2021;9(3):280. doi:10.3390/vaccines9030280.
- Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, et al. Motivating mothers to recommend their 20-year-old daughters receive cervical cancer screening: a randomized study. J Epidemiol. 2018;28(3):156–60. doi:10.2188/jea.JE20160155.